Moderna FOIA Bombshell Reveals Alarming Problems with FDA Approval of SPIKEVAX

Alexandra Latypova ("Sasha") is a retired pharmaceutical industry executive and entrepreneur. She holds an MBA degree from Dartmouth College and spent approximately 25 years in pharmaceutical research and development. Sasha later co-founded several clinical research organizations working as a contractor for about 60 pharmaceutical companies worldwide and was involved in the design, execution, data collection, analysis and submission of data to the FDA on hundreds of clinical trials.

She also interacted with the FDA as part of the scientific consortium that developed new guidance for cardiovascular safety assessments of drugs and worked in all therapeutic areas and in many countries. Sasha currently holds board positions with several medical device and health care companies.